Radiotherapy for oligometastatic tumor improved the prognosis of patients with non ‐small cell lung cancer (NSCLC)

ConclusionOligometastatic non ‐progressive NSCLC patients may benefit from aggressive radiotherapy to the residual lesions with acceptable toxicity after systemic chemotherapy.

Source: Thoracic Cancer - April 6, 2019 Category: Cancer & Oncology Authors: Hong ‐yun Gong, Yi Wang, Guang Han, Qi‐bin Song Tags: ORIGINAL ARTICLE Source Type: research